Discover 2,528 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,528
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
for
Chronic Pain
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06327542
Recruiting
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: San Francisco CA, Salt Lake City UT, Phoenix AZ,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase3, Recruiting
Agilis RF TSP Early Feasibility Study
for
Cardiac Arrythmias, Left Atrial Appendage Closure
Location: San Francisco CA, Kansas City MO, Jonesboro AR
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07361445
Recruiting
The ArtixASCEND Study
for
Acute Lower Limb Arterial Occlusion
Location: San Francisco CA, Bartlesville OK, Tulsa OK,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT07135895
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for
Microvascular Inflammation
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT07219043
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: San Francisco CA, Reno NV, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
for
Atrial Fibrillation (AF)
Location: Fremont CA, Ventura CA, West Hills CA, Pasadena CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07430956
Phase3, Recruiting
New
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
for
Locally Recurrent Head and Neck Squamous Cell Carcinoma,